II конгресс детских врачей РУз с международным участием
«Актуальные вопросы практической
педиатрии»
271
PNEUMONIA IN CHILDREN BORN TO MOTHERS WHO HAVE
COVID-19 DURING PREGNANCY
Abdurazakova Sh.A.
Tashkent Pediatric Medical Institute
Kasimova Sh.Sh.
Tashkent Pediatric Medical Institute
Khakberdieva G.E.
Tashkent Pediatric Medical Institute
Uzbekistan, Tashkent
Introduction
Around the world, the corona viral infection pandemic is one of the pressing
problems; the treatment of pregnant women and its consequences, both of the
pregnant women themselves and of newborn children born from those who have
had COVID-19, is of great importance. All over the world, bronchopulmonary
pathology, in comparison with other diseases of the bronchopulmonary system in
children, occupies one of the first places. COVID-19 in pregnant women and the
condition of infants is of great interest not only to obstetricians and gynecologists,
but also to pediatricians. On February 11, 2020, the World Health Organization
assigned the official name to the infection caused by the new corona virus
–
COVID-
19 (“Coronavirus disease 2019”). To study the course and treatment of
children under 2 years of age with pneumonia born to women who had COVID-19
during pregnancy in comparison.
Materials and methods
To solve these problems, literature data on COVID-19 infection were
studied. From the admitted patients, 8 medical histories of children aged 1 to
2 years were selected, whose mothers suffered from COVID-19 in 2020 and
10 histories from mothers who did not suffer from COVID-19. COVID-19 was
detected quite a long time before birth (the infection was diagnosed in women
from 29
–
32 weeks of pregnancy). All children upon admission had a moderate
condition and severe ones, mainly in the first group, mothers who had recovered
from COVID-19, all children had concomitant diseases. From the anamnesis it was
revealed that all patients before admission to the hospital received treatment at
the place of residence: antipyretics, antispasmodics, antibiotics and expectorants.
Although the literature notes that the COVID-19 disease does not affect infants,
children from mothers who have recovered from the disease have a weakened
immune system and respiratory diseases are much more severe. The increase in
div temperature continued for up to three days, and in the second group,
normalization of temperature was noted on day 2. During the recovery process, a
difference was also noted and sick children of the first group were discharged on
II конгресс детских врачей
РУз с международным участием
«Актуальные вопросы практической
педиатрии»
272
days 10-12, and children of the second group on days 8-10. The safety of
pharmacotherapy is, of course, of great importance in the clinical practice of any
doctor, but it plays a very special role in the practice of a pediatrician, which
requires taking into account the characteristics of the child
’
s div.
Pharmacotherapy was carried out taking into account age and concomitant
diseases. In children of the first group, concomitant grade 2 anemia was
diagnosed more than in the first; this indicator may be due to the fact that the
mothers of these children had COVID.
Results
When treating with antibacterial agents, preference was given to 3rd
generation cephalosporin drugs, anti-inflammatory drugs with antipyretic effect;
from glucocorticoids
–
dexamethasone, detoxification therapy and from the group
of vitamins ascorbic acid, physiotherapy. All drugs were prescribed taking into
account the age and severity of the pathological condition, in the required
therapeutic dose. At the end of the course of treatment, sick children were
discharged home under the supervision of a local doctor in satisfactory condition.
Conclusion
Thus, a study of the medical history of children with pneumonia showed a
comparison of two groups, showed that children from the first group, born to
mothers who had recovered from COVID-19, suffered much more severe
pneumonia compared to the second group, this was reflected in the severity of the
condition, a longer increase in temperature div and duration of the disease.
References:
1.
Махкамова, Г. Г., and Эльмира Амануллаевна Шамансурова.
"Результаты изучения этиологии крупа у детей и оценка эффективности
ингаляционных кортикостероидов." Педиатрическая фармакология 6.4
(2009): 35-39.
2.
Agzamova, Sh A. "PECULIARITIES OF LIFE QUALITY OF WOMEN DURING
POST MENOPAUSAL PERIOD WITH ARTERIAL HYPERTENSION." VI
Евразийский конгресс кардиологов. 2018.
3.
Улугов, Аскар Исматович. "Функциональные изменения в миокарде
при хронических гепатитах." Молодой ученый 22 (2016
): 113-116.
4.
Деворова, М., and Г. Махкамова. "Distinctive features and prevalence of
allergic rhinitis in children." Педиатрия 1.1 (2023): 263
-267.
5.
Агзамова, Ш. А., Ф. М. Ахмедова, and Г. М. Хасанова. "Прогностическая
роль высокочувствительного Среактивного
белка при формировании
эссенциальной артериальной гипертензии у детей." Science and Education
4.4 (2023): 362-366.
6.
Ахмедова, Д. И., and Н. Н. Эргашева. "Динамика массы тела при
врожденной кишечной непроходимости у новорожденных." Врач
-
аспирант
53.4 (2012): 70-76.
II конгресс детских врачей РУз с международным участием
«Актуальные вопросы практической
педиатрии»
273
7.
Улугов, Аскар Исматович, and Чори Жумаевич Бутаев. "Влияние
респираторных аллергических заболеваний на биофизиче
-
ские свойства
мембраны эритроцитов у детей." Евразийский Союз Ученых 5
-5 (14) (2015):
72-74.
8.
Кошимбетова, Г. К., and З. Р. Кутлимуратова. "Синдром
раздраженного кишечника как аспект функциональных заболеваний
желудочно
-
кишечного тракта." Medicus 2 (2019): 35
-37.
9.
Вахидова, Ш., and Д. Каримова. "Особенности течения
аллергических заболеваний у детей дошкольного возраста с глистной
инвазией." Научные работы одарённой молодёжи и медицина XXI века 1.1
(2023): 53-53.
10.
Очилова, Гузаль, and Бахром Очилов. "Ўзбекистон вa UNICEF
ташкилотининг ҳамкорлик алоқалари ва инсонпарварлик ғоялари."
Глобальное партнерство как условие и гарантия стабильного развития 1.1
(2021): 292-295.
